Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
Titel:
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
Auteur:
Borchmann, Peter Haverkamp, Heinz Lohri, Andreas Mey, Ulrich Kreissl, Stefanie Greil, Richard Markova, Jana Feuring-Buske, Michaela Meissner, Julia Dührsen, Ulrich Ostermann, Helmut Keller, Ulrich Maschmeyer, Georg Kuhnert, Georg Dietlein, Markus Kobe, Carsten Eich, Hans Baues, Christian Stein, Harald Fuchs, Michael Diehl, Volker Engert, Andreas